Team-Based Strategies Advance Cardio-Renal-Metabolic Health
- This article discusses several important points related to cardiovascular, renal, and metabolic (CRM) conditions and improving patient care.
- * Drug Pricing & Access: A major concern is the high cost of medications, even with discounts negotiated by large health systems like the Cleveland Clinic.
- In essence, the article points to a need for both innovative medical advancements and a focus on making those advancements accessible and beneficial to patients through affordability and...
Key Takeaways from the Article:
This article discusses several important points related to cardiovascular, renal, and metabolic (CRM) conditions and improving patient care. Here’s a breakdown of the main themes:
* Drug Pricing & Access: A major concern is the high cost of medications, even with discounts negotiated by large health systems like the Cleveland Clinic. Dr.Ash advocates for passing those discounts on to patients to improve access to care. He also suggests exploring broader solutions like public ownership of pharmaceutical distribution chains.
* New Research & Treatments: The article references several recent studies:
* Bempedoic acid: Shows positive cardiovascular outcomes in statin-intolerant patients.
* Rosuvastatin & Supplements: A comparison of effects on lipids and inflammatory biomarkers.
* Guideline-Directed Medical Therapies (GDMT): Analysis of GDMT prescription rates in patients with diabetes and chronic kidney disease.
* Tirzepatide: Demonstrates promise for metabolic dysfunction-associated steatohepatitis (MASH) with liver fibrosis.
* AI-Enabled Lifestyle Modifications: A trial showing potential for de-escalating diabetes pharmacotherapy through AI-supported lifestyle changes.
* Patient-Centered Care: Dr.Fryfogle emphasizes the importance of truly listening to patients during multidisciplinary care. He highlights the need to connect with patients on a personal level, ensuring they feel supported and empowered to advocate for their own health. This involves setting aside administrative tasks (“pushing the computer to the side”) to focus on the individual.
* Disclosure: The author, ms. Mattina, is an employee of MJH Life Sciences®, the parent company of the publisher of Population Health, Equity & outcomes.
In essence, the article points to a need for both innovative medical advancements and a focus on making those advancements accessible and beneficial to patients through affordability and compassionate care.